Close Menu
    Facebook X (Twitter) Instagram
    Latest
    • A new malpractice being observed: Reviewers asking their own papers to cite
    • 100% APC Waiver for Authors from “Group A” Category Countries Indicated by Research4Life
    • Retraction Notice: Pharmacological Actions of Impatiens
    • DOI Allocated and Activated for 281 Articles and Abstracts Published in the period of 2014-2017
    • IGJPS, 2021, Vol 11, Issue 3
    • IGJPS, 2021, Vol 11, Issue 2
    • IGJPS, 2021, Vol 11, Issue 1
    • Table of Contents, Vol 10, Issue 4
    INDO GLOBAL JOURNAL OF PHARMACEUTICAL SCIENCESINDO GLOBAL JOURNAL OF PHARMACEUTICAL SCIENCES
    • Home
    • About Us
    • Issues
      • IGJPS 2022 and Onwards
      • IGJPS, 2021, Vol 11, Issue 3
      • IGJPS, 2021, Vol 11, Issue 2
      • IGJPS, 2021, Vol 11, Issue 1
      • IGJPS, 2020, Vol 10, Issue 4
      • IGJPS, 2020, Vol 10, Issue 3
      • IGJPS, 2020, Vol 10, Issue 2
      • IGJPS, 2020, Vol 10, Issue 1
      • IGJPS, 2019, Vol 9, Issue 2 (Suppl.)
      • IGJPS, 2019, Vol 9, Issue 2
      • IGJPS, 2019, Vol 9, Issue 1
      • IGJPS, 2018, Vol 8, Issue 3
      • IGJPS, 2018, Vol 8, Issue 2
      • IGJPS, 2018, Vol 8, Issue 1
      • IGJPS, 2017, Vol 7, Issue 2
      • IGJPS, 2017, Vol 7, Issue 1
      • IGJPS, 2016, Vol 6, Issue 2
      • IGJPS, 2016, Vol 6, Issue 1
      • IGJPS, 2015, Vol 5, Issue 3
      • IGJPS, 2015, Vol 5, Issue 2
      • IGJPS, 2015, Vol 5, Issue 1
      • IGJPS, 2014, Vol 4, Issue 3
      • IGJPS, 2014, Vol 4, Issue 2
      • IGJPS, 2014, Vol4, Issue 1
      • IGJPS, 2013, Vol 3, Issue 3
      • IGJPS,2013, Vol 3, Issue 2
      • IGJPS, 2013, Vol 3, Issue 1
      • IGJPS, 2012, Vol 2, Issue 4
      • IGJPS, 2012, Vol 2, Issue 3
      • IGJPS, 2012, Vol 2, Issue 2
      • IGJPS, 2012, Vol 2, Issue 1
      • IGJPS, 2011, Vol 1, Issue 4
      • IGJPS, 2011, Vol 1, Issue 3
      • IGJPS, 2011, Vol 1, Issue 2
      • IGJPS, 2011, Vol 1, Issue 1
    • Editorial Board
    • Guidelines For Authors
    • Indexed
    • Manuscript Submission
    • Contact Us
    INDO GLOBAL JOURNAL OF PHARMACEUTICAL SCIENCESINDO GLOBAL JOURNAL OF PHARMACEUTICAL SCIENCES
    You are at:Home»News»Prof. Mohammad Amjad Kamal, Australia joined Indo Global Journal of Pharmaceutical Sciences as Associate Editor

    Prof. Mohammad Amjad Kamal, Australia joined Indo Global Journal of Pharmaceutical Sciences as Associate Editor

    0
    By Rajeev Singla on March 17, 2018 News, Slider

    I am very pleased to inform all my readers, authors and editorial board members, that Prof. Mohammad Amjad Kamal ( King Fahd Medical Research Center (KFMRC), King Abdulaziz University, Jeddah, Saudi Arabia; Enzymoics, 7 Peterlee Place, Hebersham, NSW 2770, Australia and Novel Global Community Educational Foundation (NGCEF), Australia) has joined Indo Global Journal of Pharmaceutical Sciences as Associate Editor (https://www.iglobaljournal.com/editorial-board/). Its a Congratulations Moment for Journal.

    Dr. Mohammad Amjad Kamal is a Distinguished Adjunct Professor at the King Fahd Medical Research Center (KFMRC), King Abdulaziz University, Jeddah, Saudi Arabia, where he was full Professor from March 2011 to March 2013. He is leading a highly productive global collaborative research team based from Novel Global Community Educational Foundation (NGCEF). Dr. Kamal’s biochemical research in the field of Alzheimer’s disease, Type 2 diabetes and leukemia has culminated in more than 320 publications in internationally respected journals, and 65 abstracts at international conferences.

    The daily dose of the drug shouldn’t exceed 5 mg. The long-term use of Ambien (or any other sleeping pills) it is not recommended. The duration of treatment should be as short as possible: from several days to four weeks, including a period of dose reduction. Other recomendation for Ambien (Zolpidem) on website https://holisticdental.org/ambien-treat-insomnia/.

    He is serving as external examiner for PhD thesis evaluation of various universities and as an EiC/regional/editorial member/guest editor of several reputed scientific journals – this is undertaken on an honorable basis, and includes the following:

    1. Seminars in Cancer Biology
    2. Journal of Medicinal Chemistry
    3. Current Drug Metabolism
    4. Current Pharmaceutical Design
    5. Current Alzheimer Research
    6. Neuroscience
    7. Current Medicinal Chemistry
    8. Current Topics in Medicinal Chemistry
    9. CNS & Neurological Disorders-Drug Targets
    10. BMC Neuroscience
    11. Neural Plasticity
    12. Frontiers in Aging Neuroscience
    13. Oxidative Medicine and Cellular Longevity
    14. Journal of Diabetes Research
    15. Protein & Peptide Letters
    16. Evidence-Based Complementary and Alternative Medicine
    17. Metabolic & Immune Disorders – Drug Targets
    18. Medicinal Chemistry
    19. Pharmacognosy Magazine
    20. Saudi Journal of Biological Sciences
    21. Current Psychopharmacology
    22. Molecular and Genetic Medicine
    23. Journal of Neurological Disorders
    24. Enzyme Engineering
    25. Recent Patents on Nanomedicine
    26. Journal of Advance Health Sciences
    27. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy journal
    28. Journal of Neuroprotection and Neuroregeneration
    29. Drug Designing
    30. Research Journal of Endocrinology and Metabolism
    31. Journal of Medical Disorders
    32. Journal of Molecular Biology and Techniques
    33. The Open Biochemistry Journal
    34. Current Aging Science
    35. Jacobs Journal of Drug Metabolism and Toxicology
    36. International Archives of Endocrinology Clinical Research
    37. Journal of Neurology and Psychology
    38. Enliven: Journal of Genetics, Molecular and Cellular Biology
    39. Enliven: Neurology and Neurotechnology
    40. Enliven: Pharmacovigilance and Drug Safety
    41. Sydney Journal of Medical Sciences

    I would like to personally thank Prof. Kamal for considering my request and joining our journal.

    Regards

    Rajeev K Singla

    Founder and Editor-in-Chief

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    A new malpractice being observed: Reviewers asking their own papers to cite

    100% APC Waiver for Authors from “Group A” Category Countries Indicated by Research4Life

    Retraction Notice: Pharmacological Actions of Impatiens

    Comments are closed.

    Latest News
    A new malpractice being observed: Reviewers asking their own papers to cite
    ...
    100% APC Waiver for Authors from “Group A” Category Countries Indicated by Research4Life
    ...
    Retraction Notice: Pharmacological Actions of Impatiens
    ...
    DOI Allocated and Activated for 281 Articles and Abstracts Published in the period of 2014-2017
    ...
    Top Peer Reviewer as New Associate Editor: Dr. Ghulam Md. Ashraf, King Abdulaziz University, Jeddah, Saudi Arabia
    ...
    Highly Cited Articles

    Microencapsulation–A Novel Approach in Drug Delivery: A Review

    Review on the pharmacognostical & pharmacological characterization of Apium graveolens Linn


    Medicinal Plants of Rural India: A Review of Use by Indian Folks


    Self Emulsifying Drug Delivery System: A Tool in Solubility Enhancement of Poorly Soluble Drugs


    Antioxidant and antimicrobial activities of Cocos nucifera Linn.(Arecaceae) endocarp extracts

    Impotant Links
    • About Us
    • Call For Papers
    • Contact Us
    • Editorial Board
    • For Reviewers
    • Guidelines For Authors
    • Home Page
    • Indexed
    • Issues
    • Manuscript Submission
    • Checkout
    • Transaction Results
    • Your Account
    Sponsored
    Copyright © 2011 iGlobal Research & Publishing Foundation
    Powered By :- Ganga Graphix.

    Type above and press Enter to search. Press Esc to cancel.